torcetrapib has been researched along with Electrolytes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arca, M; Asselbergs, FW; Boekholdt, SM; Cambien, F; Casas, JP; Cooper, J; D'Agostino, RB; Deanfield, J; Dullaart, RP; Ebrahim, S; Ford, I; Freeman, D; Gaudio, C; Goto, A; Gudnason, V; Hingorani, AD; Horne, BD; Humphries, SE; Isaacs, A; Kakko, S; Kastelein, JJ; Kauma, H; Kesäniemi, YA; Khaw, KT; Kivimaki, M; Kumari, M; Lawlor, DA; Li, TY; Marmot, M; McCaskie, P; McCormack, V; Navis, G; Nicaud, V; Okumura, K; Ordovas, J; Packard, C; Palmer, LJ; Paulweber, B; Pencina, M; Poirer, O; Quagliarini, F; Ricketts, SL; Sandhofer, A; Sandhu, MS; Sattar, N; Savolainen, MJ; Shah, T; Smeeth, L; Smith, GD; Sofat, R; Sorli, JV; Talmud, PJ; Thompson, JF; van der Harst, P; van Duijn, CM; Van Gilst, WH; van Veldhuisen, DJ; Vasan, RS; Wareham, N; Witteman, JC; Yokoyama, S | 1 |
1 other study(ies) available for torcetrapib and Electrolytes
Article | Year |
---|---|
Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms.
Topics: Anticholesteremic Agents; Biomarkers; Blood Pressure; Cholesterol Ester Transfer Proteins; Dose-Response Relationship, Drug; Electrolytes; Genotype; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, HDL; Polymorphism, Single Nucleotide; Quinolines; Randomized Controlled Trials as Topic; Risk Factors; White People | 2010 |